Permanent HCPCS Level II Coding for Organon’s biosimilars to PROLIA (denosumab) and XGEVA (denosumab) is now effective. Q-code: Q5162
Organon is pleased to announce that the permanent HCPCS Level II billing code for BILDYOS® (denosumab-nxxp) injection 60 mg/mL and BILPREVDA® (denosumab-nxxp) injection 120 mg/1.7 mL is now effective for billing.
The Organon Access Program may be able to answer questions about benefits investigations, billing and coding, co-pay assistance for eligible patients, and prior authorizations and appeals. You can enroll your patients here: https://www.organonaccessprogram.com/hcp/.
Providers should review their contracts and payer guides for the most accurate information. Customers are responsible for determining the correct codes when billing.
Before prescribing BILDYOS, please read the Prescribing Information, including the Boxed Warning. The Medication Guide also is available.
Before prescribing BILPREVDA, please read the Prescribing Information.
Tags: national organization of rheumatology managers, NORM, Organon Posted by










